Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy

American Journal of Cardiology

Volumn 93, Issue 1, 2004, Pages 45-48

  Li, Huagui ^a   Riedel, Roger ^a   Oldemeyer, J Bradley ^a   Rovang, Karen ^a   Hee, Tom ^a  

^a CREIGHTON UNIVERSITY CARDIAC CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DISOPYRAMIDE; FLECAINIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL FEATURE; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIRECT CURRENT; EVALUATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; SCREENING; TREATMENT FAILURE;

EID: 0347063916     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.09.010     Document Type: Article

References (7)

1. A Comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 347:2002;1825-1833.
2. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns JGM, for the Rate Control versus Electrical Cardioversion for Perisistent Atrial Fibrillation Study Group. N Engl J Med. 347:2002;1834-1840.
3. Van Gelder I.C., Crijns H.J.G.M., van Gilst W.H., van Wijk L.M., Hamer H.P.M., Lie K.I. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol. 64:1989;1317-1321.
4. Juul-Moller S., Edvardsson N., Rehnqvist-Ahlberg N. Sotalol versus quinidine for maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation. 82:1990;1932-1939.
5. Gosselink A.T.M., Crijns H.J.G.M., van Gelder I.C., Hillige H., Wiesfeld A.C.P., Lie K.I. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA. 267:1992;3289-3293.
6. Stroobandt R., Stiels B., Hoebrechts R. Propafenone for conversion and prophylaxis of atrial fibrillation. Am J Cardiol. 79:1997;418-423.
7. Van Gelder I.C., Crijns H.J., Tieleman R.G., Brugemann J., De Kam P.J., Gosselink A.T., Verheugt F.W., Lie K.I. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Ann Intern Med. 156:1996;2585-2592.